The Effects of a Peer Co-led Educational Programme for Parents of Children With ADHD (ADHD)
Primary Purpose
Attention Deficit Disorder With Hyperactivity
Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Peer co-led educational group
Comparator treatment as usual
Sponsored by
About this trial
This is an interventional treatment trial for Attention Deficit Disorder With Hyperactivity focused on measuring Parental activation, Peer co-led education
Eligibility Criteria
Inclusion Criteria:
- Parents of children aged 6 - 12 with a formal diagnosis of ADHD, following a standardised assessment.
Exclusion Criteria:
- Participants already taking part in research on a parenting intervention will also be ineligible to participate.
- Families attending other parenting groups
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Other
Arm Label
Peer co-led educational group
Control group
Arm Description
The intervention delivered in a group format is added to treatment as usual. After the parents participate in the one day-intervention, they can continue in self-help groups, which meet once a week for a 2-hour evening session. User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence.
The control goup will receive treatment as usual.
Outcomes
Primary Outcome Measures
Feasibility of recruitment
Feasibility of recruitment will be assessed by determining the recruitment rate, by monitoring patient screening and subsequent agreement to participate.
Satisfaction with the intervention
Parent satisfaction will be measured by means of the client satisfaction Questionnaire, CSQ-3 as it applies to the group-based educational programme. The scale comprises three items measured on a scale from 1 (not satisfied) to 4 (very satisfied).
Parental activation
Parental activation will be measure with the P-PAM-13. The 13-items P-PAM has four possible response options ranging from (1) strongly disagree, to (4) strongly agree, and an additional 'not applicable' option.
Secondary Outcome Measures
Parental well-being
Parental well-being will be measured by the WHO-5 Well-being Index. The questionnaire has five items rated on a six-point scale from 0 (all the time) to 5 (at no time); this items are transformed into 0-100 scales (high scores indicate a better well-being).
Parental quality of life
Parental quality of life will be measured by the 10- items Multicultural Quality of Life Index (MQLI) which cover key aspects of the concept, from physical well-being to spiritual fulfilment. The MQLI questionnaire has ten items.
Shared decision making
It will be assessed using a modified version of the Control Preferences Scale to provide information about the parent's preferred role in involvement.
Parental involvement in treatment decision
Parent involvement will be assessed using a modified version of the CollaboRATE scale
Beliefs about medicines
To investigate the beliefs about medicines we will use the Beliefs about Medicines Questionnaire (BMQ).
Adherence
To investigate medication adherence using the Medication Adherence Rating Scale 5 items.
ADHD Scale Parent Version
The SNAP-IV 18-Item will be use to evaluate ADHD, the SNAP-IV 18-Item Scale Parent Version is an abbreviated version of the Swanson, Nolan, and Pelham (SNAP). The questionnaire includes items for the two subsets of symptoms, inattention (items 1-9) and hyperactivity/impulsivity (items 10-18), from the DSM-IV criteria for ADHD. The scores in each of the two subsets are added together. SNAP-IV is used to measure ADHD symptoms and behavioral problems in school-aged children. Symptom severity is rated on a 4-point scale.
Level of functioning of children in Child
The C-GAS will be used to assess the overall level of functioning of children. The C-GAS is a numeric scale ranging from 1 to 100 used to assess the overall level of functioning of children in Child and Adolescent Mental Health Services, with high scores indicating better functioning.
Full Information
NCT ID
NCT04010851
First Posted
June 28, 2019
Last Updated
January 29, 2022
Sponsor
Norwegian University of Science and Technology
Collaborators
St. Olavs Hospital, Molde University College
1. Study Identification
Unique Protocol Identification Number
NCT04010851
Brief Title
The Effects of a Peer Co-led Educational Programme for Parents of Children With ADHD
Acronym
ADHD
Official Title
The Effects of a Peer Co-led Educational Programme for Parents of Children With ADHD: A Feasibility Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
January 2022
Overall Recruitment Status
Withdrawn
Why Stopped
to much uncertainty about possibilities for recruiting
Study Start Date
March 2022 (Anticipated)
Primary Completion Date
July 1, 2023 (Anticipated)
Study Completion Date
July 1, 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Norwegian University of Science and Technology
Collaborators
St. Olavs Hospital, Molde University College
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
ADHD is associated with a substantial burden on families, and systems pertaining to health, social care, and criminal justice, and there is a need for more knowledge of the effects of non-pharmacological interventions. Educational and parental activation interventions may improve ADHD symptoms, and may enhance parent activation. Although the results of these studies are promising, few interventions have been carried out in collaboration with user representatives, which is required by Norwegian legislation. As such, there is a need for clinical studies that document the effects of educational group interventions based on user involvement that seeks to improve parental activation. Furthermore, it is not clear which type of educational intervention that should be offered, and which aspects of parenting behaviour to focus on. There is a lack of studies investigating whether adding an intervention designed specifically for families of children with ADHD will be more effective than treatment as usual (TAU). The purpose of the present study is to determine the feasibility and expected size of a substantive randomized controlled trial comparing an ADHD peer co-led educational programme added to TAU.
Detailed Description
The primary objective of this trial is to evaluate the acceptability and feasibility of the intervention, to assure that procedures are adequate for a subsequent full size randomized controlled trial (RCT), and to determine the likely size of the trial comparing an ADHD specific parenting peer co-led intervention for parents of children with ADHD symptoms.
Specific objectives are:
(I) investigate whether parents of children recently diagnosed with ADHD are willing to be randomized to the intervention, (II) whether sufficient numbers of families can be recruited and retained such that a full-scale RCT is likely to be feasible, (III) whether research procedures and efficacy measures are feasible and acceptable to participating families and the outpatient clinics, and (IV) whether families participating in the intervention are satisfied with the intervention.
This feasibility study is not designed to detect a treatment effect, therefore a maximum of 50 parents will be recruited. The measurements will be taken in the children (at baseline and 3 months) and parents (at baseline, two weeks, pre-post intervention and 3 months follow-up) to determine the feasibility and acceptability. These measures are chosen because they address key components of the intervention (activation, quality of life and psychological well-being). Multiple measures of similar constructs will be administered where possible (e.g., psychological well-being and quality of life) to determine which measure to include in the definitive trial according to feasibility, acceptability, and sensitivity.
Feasibility assessments:
Feasibility of recruitment.
Acceptability of randomization and procedures will be determined by measuring loss to follow-up (post-test and 3-month follow-up), and reasons for withdrawal will be used collected.
Acceptability of the intervention will be determined based on the number of sessions attended by participants in the peer co-led education. We will also reported on satisfaction with the program.
Feasibility of quantitative measures will be deemed acceptable if no questionnaires are missing in full in more than 25% of the participants and if reliability was higher than 0.70.
Follow-up response rates (post-intervention and 3 months follow-ups).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Attention Deficit Disorder With Hyperactivity
Keywords
Parental activation, Peer co-led education
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
The intervention is delivered in a group format, which takes the form of a full day's training, focusing on ADHD diagnosis, its treatment, how to cope with the challenges related to living with ADHD, as well as coping with challenges of parenting a child with chronic health conditions. After this one day-intervention, the participants can continue in self-help groups, which meet once a week for a 2-hour evening session. User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence. Participants are encouraged to adopt an active role in order to achieve a positive parent/provider partnership.
Masking
None (Open Label)
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Peer co-led educational group
Arm Type
Experimental
Arm Description
The intervention delivered in a group format is added to treatment as usual. After the parents participate in the one day-intervention, they can continue in self-help groups, which meet once a week for a 2-hour evening session. User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence.
Arm Title
Control group
Arm Type
Other
Arm Description
The control goup will receive treatment as usual.
Intervention Type
Behavioral
Intervention Name(s)
Peer co-led educational group
Intervention Description
The intervention is delivered in a group format, which takes the form of a full day's training, focusing on ADHD diagnosis, its treatment, how to cope with the challenges related to living with ADHD, as well as coping with challenges of parenting a child with chronic health conditions. After this one day-intervention, the participants can continue in self-help groups, which meet once a week for a 2-hour evening session. User representatives lead these weekly self-help groups, which do not require user-fees and aim to offer practical tools, support and information to increase the parent's skills, knowledge and confidence. Participants are encouraged to adopt an active role in order to achieve a positive parent/provider partnership.
Intervention Type
Behavioral
Intervention Name(s)
Comparator treatment as usual
Intervention Description
Control group will receive treatment as usual, including different treatment options that can help alleviate the symptoms of ADHD and arm families with the tools needed to better handle problem behaviors when they arise. These interventions include: medication, psychotherapy, or a combination of these two approaches.
Primary Outcome Measure Information:
Title
Feasibility of recruitment
Description
Feasibility of recruitment will be assessed by determining the recruitment rate, by monitoring patient screening and subsequent agreement to participate.
Time Frame
Over a two year study period
Title
Satisfaction with the intervention
Description
Parent satisfaction will be measured by means of the client satisfaction Questionnaire, CSQ-3 as it applies to the group-based educational programme. The scale comprises three items measured on a scale from 1 (not satisfied) to 4 (very satisfied).
Time Frame
From baseline to 12- and 52-weeks follow-up
Title
Parental activation
Description
Parental activation will be measure with the P-PAM-13. The 13-items P-PAM has four possible response options ranging from (1) strongly disagree, to (4) strongly agree, and an additional 'not applicable' option.
Time Frame
From baseline to 12- and 52-weeks follow-up
Secondary Outcome Measure Information:
Title
Parental well-being
Description
Parental well-being will be measured by the WHO-5 Well-being Index. The questionnaire has five items rated on a six-point scale from 0 (all the time) to 5 (at no time); this items are transformed into 0-100 scales (high scores indicate a better well-being).
Time Frame
From baseline to 12- and 52-weeks follow-up
Title
Parental quality of life
Description
Parental quality of life will be measured by the 10- items Multicultural Quality of Life Index (MQLI) which cover key aspects of the concept, from physical well-being to spiritual fulfilment. The MQLI questionnaire has ten items.
Time Frame
From baseline to 12- and 52-weeks follow-up
Title
Shared decision making
Description
It will be assessed using a modified version of the Control Preferences Scale to provide information about the parent's preferred role in involvement.
Time Frame
From baseline to 12- and 52-weeks follow-up
Title
Parental involvement in treatment decision
Description
Parent involvement will be assessed using a modified version of the CollaboRATE scale
Time Frame
From baseline to 12- and 52-weeks follow-up
Title
Beliefs about medicines
Description
To investigate the beliefs about medicines we will use the Beliefs about Medicines Questionnaire (BMQ).
Time Frame
From baseline to 12- and 52-weeks follow-up
Title
Adherence
Description
To investigate medication adherence using the Medication Adherence Rating Scale 5 items.
Time Frame
From baseline to 12- and 52-weeks follow-up
Title
ADHD Scale Parent Version
Description
The SNAP-IV 18-Item will be use to evaluate ADHD, the SNAP-IV 18-Item Scale Parent Version is an abbreviated version of the Swanson, Nolan, and Pelham (SNAP). The questionnaire includes items for the two subsets of symptoms, inattention (items 1-9) and hyperactivity/impulsivity (items 10-18), from the DSM-IV criteria for ADHD. The scores in each of the two subsets are added together. SNAP-IV is used to measure ADHD symptoms and behavioral problems in school-aged children. Symptom severity is rated on a 4-point scale.
Time Frame
From baseline to 12- and 52-weeks follow-up
Title
Level of functioning of children in Child
Description
The C-GAS will be used to assess the overall level of functioning of children. The C-GAS is a numeric scale ranging from 1 to 100 used to assess the overall level of functioning of children in Child and Adolescent Mental Health Services, with high scores indicating better functioning.
Time Frame
From baseline to 12- and 52-weeks follow-up
Other Pre-specified Outcome Measures:
Title
Participation in treatment
Description
Information regarding treatment participation and use of services will be collected via Patient Administrative System (PAS).
Time Frame
From baseline to 12- and 54-weeks follow-up.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Parents of children aged 6 - 12 with a formal diagnosis of ADHD, following a standardised assessment.
Exclusion Criteria:
Participants already taking part in research on a parenting intervention will also be ineligible to participate.
Families attending other parenting groups
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ingunn P. Mundal, PhD
Organizational Affiliation
Molde University College
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Mariela Loreto Lara Cabrera, PhD
Organizational Affiliation
St Olavs Hospital, Department of research and development AFFU, and NTNU
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Rolf W. Gråwe, Phd prof
Organizational Affiliation
Norwegian University of Science and Technology
Official's Role
Study Director
12. IPD Sharing Statement
Plan to Share IPD
No
IPD Sharing Plan Description
We anticipate that anonymised trial data may be shared with other researchers to enable international prospective meta-analyses.
Citations:
PubMed Identifier
33268416
Citation
Mundal I, Grawe RW, Hafstad H, De Las Cuevas C, Lara-Cabrera ML. Effects of a peer co-facilitated educational programme for parents of children with ADHD: a feasibility randomised controlled trial protocol. BMJ Open. 2020 Dec 2;10(12):e039852. doi: 10.1136/bmjopen-2020-039852.
Results Reference
derived
Learn more about this trial
The Effects of a Peer Co-led Educational Programme for Parents of Children With ADHD
We'll reach out to this number within 24 hrs